ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus

By Rimmelzwaan G.F.   Claas E.C.J.   Van Amerongen G.   de Jong J.C.   Osterhaus A.D.M.E.  

Vaccine, Vol. 17, Iss. 11, 1999-03 ,pp. : 1355-1358

Elsevier

Access to resources Recommend Favorite

Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase

By Chen Z.   Kadowaki S.-E.   Hagiwara Y.   Yoshikawa T.   Matsuo K.   Kurata T.   Tamura S.-I.  

Vaccine, Vol. 18, Iss. 28, 2000-08 ,pp. : 3214-3222

Elsevier

Access to resources Recommend Favorite

Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infection

By Huisman W.   Karlas J.A.   Siebelink K.H.J.   Huisman R.C.   de Ronde A.   Francis M.J.   Rimmelzwaan G.F.   Osterhaus A.D.M.E.  

Vaccine, Vol. 16, Iss. 2, 1998-01 ,pp. : 181-187

Elsevier

Access to resources Recommend Favorite

Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine

By Nichol K.L.   Mallon K.P.   Mendelman P.M.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 2216-2226

Elsevier

Access to resources Recommend Favorite

Persistent infection of influenza virus in irradiated mice and its prevention by intranasal vaccination

By Hasegawa H.   Kadowaki S.-e.   Watanabe I.   Aizawa H.   Takahashi H.   Iwasaki T.   Tamura S.-i.   Kurata T.   Sata T.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1050-1057

Elsevier

Access to resources Recommend Favorite